Drug Type Monoclonal antibody |
Synonyms CR 8033 |
Target |
Mechanism hemagglutinin inhibitors(Influenza virus hemagglutinin glycoproteins inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza B virus infection | Preclinical | US | 13 Sep 2012 | |
Influenza B virus infection | Preclinical | CN | 13 Sep 2012 |